Results 61 to 70 of about 26,786 (248)

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

, 2011
Coronary artery disease (CAD) is frequently present in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).
Thierry Carrel, Windecker, Stephan, Buellesfeld, Lutz, Guerios, Enio, Thomas Pilgrim, Peter Wenaweser, Bernhard Meier, Wenaweser, Peter, Christoph Huber, Stortecky, Stefan, Huber, Christoph, Carrel, Thierry, Stephan Windecker, Steffen Gloekler, Lutz Buellesfeld, Pilgrim, Thomas, Ahmed A. Khattab, Kadner, Alexander, Enio Guerios, Khattab, Ahmed A, Gloekler, Steffen, Meier, Bernhard, Stefan Stortecky, Alexander Kadner   +23 more
core   +1 more source

Percutaneous coronary artery intervention after transcatheter aortic valve implantation [PDF]

, 2021
Transcatheter implantation of the aortic valve is an increasingly used method for the treatment of aortic stenosis, with a steady trend worldwide to increase the number of TAVI procedures and reduce the age of patients.
Petar Polomski, Mariya Dotseva, Tasheva, Iveta, Cherneva,Aleksandra, Georgi Dobrev, Dotseva, Mariya, Tsareva, Inna, Stankov, Zoran, Stankov,Zoran, Aleksandra Cherneva, Cherneva, Aleksandra, Petrov,Ivo, Petrov, Ivo, Dotseva,Mariya, Ivo Petrov, Polomski, Petar, Iveta Tasheva, Inna Tsareva, Dobrev, Georgi, Царева,Инна, Dobrev,Georgi, Zoran Stankov, Tasheva,Iveta, Polomski,Petar   +23 more
core   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source

Utility of virtual reality imaging to guide complex structural cardiac interventions: A randomized controlled trial

Annals of Pediatric Cardiology
Background: Accurate preprocedural planning is critical for complex transcatheter structural heart interventions. Virtual reality (VR) enhanced imaging may improve accuracy compared to conventional computed tomography (CT) and may reduce variability ...
Ishita Garg, Pramod Sagar, Puthiyedath Thejaswi, Kothandam Sivakumar   +3 more
doaj   +1 more source

Transcatheter Tricuspid Interventions: Past, Present, and Future

Methodist DeBakey Cardiovascular Journal, 2023
Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis independent of all other variables.
Colin M. Barker, Kashish Goel
openaire   +3 more sources

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Transcatheter Intervention for Complex Ascending Aortic Pseudoaneurysm After Cardiac Surgery

, 2017
Background: Ascending aortic pseudoaneurysm (PsA) is an uncommon but surgically challenging problem with high morbidity and mortality. Herein we describe the efficacy and safety of the different approaches to transcatheter intervention for repair of ...
Yin, Wei-Hsian;Wei, Jeng;Tsai, Shen Kou;Hsiung, Ming C.;Lee, Yung-Tsai;Yu, Ho-Ping;Ou, Ching-Huei
core   +1 more source

Simultaneous transcatheter intervention for atrial septal defect complicated with patent ductus arteriosus: A 13-year single institutional retrospective study

Journal of Interventional Medicine, 2018
: Purpose: The feasibility and validity of simultaneous transcatheter interventions for patients with atrial septal defect (ASD) complicated with patent ductus arteriosus (PDA) has not been systematically evaluated.Materials and Methods: A retrospective ...
Qiguang Wang, Xianyang Zhu, Zhongchao Wang, Chunsheng Cui, Duanzhen Zhang, Chuanju Hou, Po Zhang, Huoyuan Chen, Lili Meng   +8 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source